BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22314100)

  • 1. Cancer cell senescence: a new frontier in drug development.
    Cairney CJ; Bilsland AE; Evans TR; Roffey J; Bennett DC; Narita M; Torrance CJ; Keith WN
    Drug Discov Today; 2012 Mar; 17(5-6):269-76. PubMed ID: 22314100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cellular senescence in cancer therapy: is it true or not?
    Zhang Y; Yang JM
    Acta Pharmacol Sin; 2011 Oct; 32(10):1199-207. PubMed ID: 21909124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA and senescence: the senectome, integration and distributed control.
    Bilsland AE; Revie J; Keith W
    Crit Rev Oncog; 2013; 18(4):373-90. PubMed ID: 23614622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor senescence as a determinant of drug response in vivo.
    Roninson IB
    Drug Resist Updat; 2002 Oct; 5(5):204-8. PubMed ID: 12450785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Senescence-Inducing Small Molecules for Cancer Treatment.
    Liu P; Lu Z; Wu Y; Shang D; Zhao Z; Shen Y; Zhang Y; Zhu F; Liu H; Tu Z
    Curr Cancer Drug Targets; 2019; 19(2):109-119. PubMed ID: 29848278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.
    Beck J; Turnquist C; Horikawa I; Harris C
    Carcinogenesis; 2020 Aug; 41(8):1017-1029. PubMed ID: 32619002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
    Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of autophagy in escaping therapy-induced polyploidy/senescence.
    Dudkowska M; Staniak K; Bojko A; Sikora E
    Adv Cancer Res; 2021; 150():209-247. PubMed ID: 33858597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular senescence in the development and treatment of cancer.
    Saretzki G
    Curr Pharm Des; 2010 Jan; 16(1):79-100. PubMed ID: 20214620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Senescence: The Sought or the Unwanted?
    Sun Y; Coppé JP; Lam EW
    Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment.
    Lee CS; Baek J; Han SY
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28841181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer biomarkers: selecting the right drug for the right patient.
    Kelloff GJ; Sigman CC
    Nat Rev Drug Discov; 2012 Feb; 11(3):201-14. PubMed ID: 22322254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies.
    Skrzeszewski M; Maciejewska M; Kobza D; Gawrylak A; Kieda C; Waś H
    Biochem Pharmacol; 2024 Jul; 225():116277. PubMed ID: 38740222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors.
    Abdelgawad IY; Agostinucci K; Zordoky BN
    Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166352. PubMed ID: 35041996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence.
    Chao SK; Horwitz SB; McDaid HM
    Oncotarget; 2011; 2(1-2):89-98. PubMed ID: 21399233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?
    Kapor S; Čokić V; Santibanez JF
    Oxid Med Cell Longev; 2021; 2021():7753857. PubMed ID: 34707779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity.
    Guillon J; Petit C; Toutain B; Guette C; Lelièvre E; Coqueret O
    Cell Cycle; 2019 Oct; 18(19):2385-2397. PubMed ID: 31397193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting cellular senescence to treat cancer and circumvent drug resistance.
    Yan Q; Wajapeyee N
    Cancer Biol Ther; 2010 Feb; 9(3):166-75. PubMed ID: 20118655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges with biomarkers in cancer drug discovery and development.
    Ileana Dumbrava E; Meric-Bernstam F; Yap TA
    Expert Opin Drug Discov; 2018 Aug; 13(8):685-690. PubMed ID: 29792354
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer stem cell targeted therapy: progress amid controversies.
    Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
    Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.